Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines

被引:16
|
作者
Cozzi, Nicholas V. [1 ,2 ]
Daley, Paul F. [1 ]
机构
[1] Alexander Shulgin Res Inst, 1483 Shulgin Rd, Lafayette, CA 94549 USA
[2] Univ Wisconsin, Sch Med & Publ Hlth, Dept Cell & Regenerat Biol, Neuropharmacol Lab,Med Sci Ctr 2695, 1300 Univ Ave, Madison, WI 53706 USA
关键词
DALT; Psychedelic; QSAR; Tryptamine; N; N-Diallyltryptamine; 5-Methoxy-N; N-diallyltryptamine; Hallucinogen; Receptor binding; Psychopharmacology; LIQUID-CHROMATOGRAPHY; PSYCHOACTIVE-DRUGS; GC-MS; SIGMA; METABOLISM; 5-HT2A;
D O I
10.1016/j.bmcl.2015.12.053
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
N,N-Diallyltryptamine (DALT) and 5-methoxy-N,N-diallyltryptamine (5-MeO-DALT) are two tryptamines synthesized and tested by Alexander Shulgin. In self-experiments, 5-MeO-DALT was reported to be psychoactive in the 12-20 mg range, while the unsubstituted compound DALT had few discernible effects in the 42-80 mg range. Recently, 5-MeO-DALT has been used in nonmedical settings for its psychoactive effects, but these effects have been poorly characterized and little is known of its pharmacological properties. We extended the work of Shulgin by synthesizing additional 5-substituted-DALTs. We then compared them to DALT and 5-MeO-DALT for their binding affinities at 45 cloned receptors and transporter proteins. Based on in vitro binding affinity, we identified 27 potential receptor targets for the 5-substituted- DALT compounds. Five of the DALT compounds had affinity in the 10-80 nM range for serotonin 5-HT1A and 5-HT2B receptors, while the affinity of DALT itself at 5-HT1A receptors was slightly lower at 100 nM. Among the 5-HT2 subtypes, the weakest affinity was at 5-HT2A receptors, spanning 250-730 nM. Five of the DALT compounds had affinity in the 50-400 nM range for serotonin 5-HT1D, 5-HT6, and 5-HT7 receptors; again, it was the unsubstituted DALT that had the weakest affinity at all three subtypes. The test drugs had even weaker affinity for 5-HT1B, 5-HT1E, and 5-HT5A subtypes and little or no affinity for the 5-HT3 subtype. These compounds also had generally nanomolar affinities for adrenergic alpha(2A), alpha(2B), and alpha(2C) receptors, sigma receptors sigma(1) and sigma(2), histamine H-1 receptors, and norepinephrine and serotonin uptake transporters. They also bound to other targets in the nanomolar-to-low micromolar range. Based on these binding results, it is likely that multiple serotonin receptors, as well as several non-serotonergic sites are important for the psychoactive effects of DALT drugs. To learn whether any quantitative structure-affinity relationships existed, we evaluated correlations among physicochemical properties of the congeneric 5-substituted-DALT compounds. The descriptors included electronic (sigma(p)), hydrophobic (pi), and steric (CMR) parameters. The binding affinity at 5-HT1A, 5-HT1D, 5-HT7, and kappa opioid receptors was positively correlated with the steric volume parameter CMR. At alpha(2A), alpha(2B), and alpha(2C) receptors, and at the histamine H-1 receptor, binding affinity was correlated with the Hammett substituent parameter sigma(p); higher affinity was associated with larger sigma(p) values. At the sigma(2) receptor, higher affinity was correlated with increasing p. These correlations should aid in the development of more potent and selective drugs within this family of compounds. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:959 / 964
页数:6
相关论文
共 50 条
  • [1] A structure-affinity study of the opioid binding of some 3-substituted morphinans
    Gómez-Jeria, JS
    Gerli-Candia, LA
    Hurtado, SM
    JOURNAL OF THE CHILEAN CHEMICAL SOCIETY, 2004, 49 (04) : 307 - 312
  • [2] 5-HT5A serotonin receptor binding: A preliminary structure-affinity investigation
    Teitler, M
    Scheick, C
    Howard, P
    Sullivan, JE
    Iwamura, T
    Glennon, RA
    MEDICINAL CHEMISTRY RESEARCH, 1997, 7 (04) : 207 - 218
  • [3] STRUCTURE-AFFINITY BINDING RELATIONSHIPS OF SOME 4-AMINOAZOBENZENE DERIVATIVES FOR CELLULOSE FIBER
    TIMOFEI, S
    KURUNCZI, L
    SCHMIDT, W
    SIMON, Z
    DYES AND PIGMENTS, 1995, 29 (03) : 251 - 258
  • [4] Synthesis, structure-affinity relationships, and biological activities of ligands binding to retinoic acid receptor subtypes
    Charpentier, B
    Bernardon, JM
    Eustache, J
    Millois, C
    Martin, B
    Michel, S
    Shroot, B
    JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (26) : 4993 - 5006
  • [5] Structure-affinity relationships by the MTD method for binding to cellulose fibre of some heterocyclic monoazo dyes
    Timofei, S
    Kurunczi, L
    Simon, Z
    MATCH-COMMUNICATIONS IN MATHEMATICAL AND IN COMPUTER CHEMISTRY, 2001, (44) : 349 - 360
  • [6] Structure-affinity relationships of a unique nicotinic ligand:: N1-dimethyl-N4-phenylpiperazinium iodide (DMPP)
    Romanelli, MN
    Manetti, D
    Scapecchi, S
    Borea, PA
    Dei, S
    Bartolini, A
    Ghelardini, C
    Gualtieri, F
    Guandalini, L
    Varani, K
    JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (23) : 3946 - 3955
  • [7] Design, Synthesis, and Structure-Affinity Relationships of Regioisomeric N-Benzyl Alkyl Ether Piperazine Derivatives as σ-1 Receptor Ligands
    Moussa, Iman A.
    Banister, Samuel D.
    Beinat, Corinne
    Giboureau, Nicolas
    Reynolds, Aaron J.
    Kassiou, Michael
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (16) : 6228 - 6239
  • [8] 5-HT6 serotonin receptor binding of indolealkylamines:: A preliminary structure-affinity investigation
    Glennon, RA
    Bondarev, M
    Roth, B
    MEDICINAL CHEMISTRY RESEARCH, 1999, 9 (02) : 108 - 117
  • [9] Structure-affinity relationship studies on benzotriazole derivatives binding to 5-HT receptor subtypes
    Caliendo, G
    Greco, G
    Grieco, P
    Novellino, E
    Perissutti, E
    Santagada, V
    Barbarulo, D
    Esposito, E
    DeBlasi, A
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1996, 31 (03) : 207 - 213
  • [10] N1-Substituted Quinoxaline-2,3-dionesas Kainate Receptor Antagonists: X-ray Crystallography, Structure-Affinity Relationships, and in Vitro Pharmacology
    Pallesen, Jakob
    Mollerud, Stine
    Frydenvang, Karla
    Pickering, Darryl S.
    Bornholdt, Jan
    Nielsen, Birgitte
    Pasini, Diletta
    Han, Liwei
    Marconi, Laura
    Kastrup, Jette Sandholm
    Johansen, Tommy N.
    ACS CHEMICAL NEUROSCIENCE, 2019, 10 (03): : 1841 - 1853